Lakefront Biotherapeutics (GLPGF) Other financing activities (2014 - 2017)

Lakefront Biotherapeutics (GLPGF) has reported Other financing activities for 3 consecutive years, with $7.7 million the latest figure, recorded in Q4 2017.

• On a quarterly basis, Other financing activities rose 2920.9% year-over-year to $7.7 million in Q4 2017; TTM through Dec 2017 was -$478.2 million, a N/A change from a year earlier, with the FY2017 full-year figure at $7.7 billion, up 2846.31% from the prior year.
• Other financing activities was $7.7 million for Q4 2017 at Lakefront Biotherapeutics, up from -$7.7 billion in the prior quarter.
• Over five years, Other financing activities peaked at $7.2 billion in Q2 2017 and troughed at -$7.7 billion in Q3 2017.
• A 3-year average of -$81.2 million and a median of $3.6 million in 2016 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 2920.9% in 2017, down 2920.9% in 2017.
• Over 3 years, Other financing activities stood at -$9.3 million in 2014, then surged by 102.74% to $253735.2 in 2016, then surged by 2920.9% to $7.7 million in 2017.
• The last three Other financing activities figures came in at $7.7 million (Q4 2017), -$7.7 billion (Q3 2017), and $7.2 billion (Q2 2017), per Business Quant data.